Nidal Karim Al-Rahal, Oula Abdullah Najim, Ahmed Shemran Alwataify, Israa Mustafa Almusawi, Ahmed Ibrahim Shukr, Yaser Shanyor Alsalman. (2022). Emicizumab Prophylaxis Every Four weeks among Hemophilia a with Inhibitors in Iraq, Multicenter Study. Journal for ReAttach Therapy and Developmental Diversities, 5(2s), 477–482. Retrieved from https://jrtdd.com/index.php/journal/article/view/170